Learning Objectives

Upon completion of this activity, participants should be able to:

• Summarize the epidemiology and pathophysiology of T-cell lymphomas
• Describe standard and emerging treatment options for patients with T-cell lymphomas
• Differentiate clinical presentation and diagnosis of cutaneous T-cell lymphomas vs peripheral T-cell lymphomas

Abstract

• Click here to view abstract

Learning Objectives

Upon completion of this activity, participants should be able to:

• Discuss the current standard of care for patients with peripheral T-cell lymphomas
• Compare the efficacy of CHOP with emerging options for the treatment of peripheral T-cell lymphomas
• Describe emerging novel agents for the treatment of peripheral T-cell lymphomas
• Analyze the role of stem cell transplantation in the treatment of peripheral T-cell lymphomas

Learning Objectives

Upon completion of this activity, participants should be able to:

• Discuss the pathogenesis of mycosis fungoides and Sézary syndrome, the most common variants of cutaneous T-cell lymphomas
• Describe the prognostic groups of cutaneous T cell lymphomas
• Summarize the therapeutic overview and treatment algorithm for treating cutaneous T-cell lymphoma patients
• Cite the efficacy and safety profiles of standard and emerging therapeutic options for treating patients with cutaneous T-cell lymphoma